Omeros Corp - OMER Net Assets per Single Share

Omeros (OMER) - corporate logo

Omeros Corporation (OMER) is implementing automated stations for the precision analysis of small molecules, eliminating human error in the search for CNS drugs. This chart illustrates the current market value on the GURU.Markets platform, where the indicator stands at -0.71, confirming the value of a targeted therapy ecosystem for rare pathologies featuring unique MASP-2 inhibitors. The business relies on contract manufacturing and outsourced clinical trial management.

Omeros Corp. (OMER) Equity per Share: for the period 07/04/2022 - 10/29/2026

Omeros Corp - analytical breakdowns and key metrics (OMER)

- price and consensus price forecast:
Stock Price Omeros Corp.|OMER - Average Forecast Price
- market capitalization data:
Market Value Omeros Corporation|OMER - Value Adjusted for Debt and Cash
- book capitalization data:
Net Assets per Single Share Omeros|OMER - Accounting Capitalization|Market Capitalization to Book Value Ratio omeros.com|OMER - Company Assets
- debt and liquidity data:
Total Debt to Equity Ratio Omeros Corporation|OMER - Long-Term Debt to Capital|Short-Term Debt to Equity Omeros Corp.|OMER - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Omeros Corporation|OMER - Long-Term Debt|Company Short-Term Debt Omeros
Fundamental company valuation:omeros.com, OMER
Manufactured products of Omeros Corp.

Book value per share reflects the portion of equity attributable to a single security after deducting all liabilities, serving as a measure of the business's actual tangible asset backing. Analyzing the book value per share chart for Omeros Corporation (OMER), an investor can see the capitalization of exclusive rights to molecules, which create long-term barriers for competitors and guarantee asset stability.

Competitor analysis for Omeros Corporation

BIIB (Biogen Corp) - Book Value per Share|NBIX: Net Asset Value per Share|Net Assets per Single Share Regencell Bioscience RGC|AXSM (axsome.com) - Accounting Value of a Share|Net Assets per Single Share ACADIA Pharmaceuticals Inc. (ACAD)|Equity per Share Xenon Pharmaceuticals Inc.|Viking Pharma - Book Value per Share|Net Asset Value per Share Supernus Corp SUPN|Accounting Value per Share CPRX (Catalyst Pharmaceuticals)|denalitherapeutics.com - Book Value per Share|Net Assets per Single Share Harmony Biosciences Holdings, Inc. (HRMY)|BHVN: Accounting Value of a Share|Net Assets per Single Share AMLX|TRVI (Trevi Corp) - Net Asset Value per Share|Net Assets per Single Share PRAX (Praxis Precision Medicines)|Net Asset Value per Share AVXL|Net Assets per Single Share CBLL (CeriBell)|Accounting Value per Share Prothena Corporation (PRTA)|ALEC: Book Value per Share|Annexon Biosciences Inc. - Net Asset Value per Share|Net Assets per Single Share Neurogene Inc. (NGNE)|ACIU: Accounting Value of a Share|Net Assets per Single Share VYGR|NMRA (Neumora) - Net Asset Value per Share|SCLX: Net Assets per Single Share|Net Assets per Share Tevogen Bio Inc. (TVGN)|Alpha Cognition (ACOG) - Accounting Value per Share|Accounting Value of a Share Cognition Therapeutics Inc. (CGTX)|Inhibikase Therapeutics, Inc. - Book Value per Share|Cassava Sciences Inc - Accounting Value per Share|ASRT (Assertio Therapeutics) - Net Assets per Single Share|COYA: Net Asset Value per Share|Net Assets per Single Share vistagen.com VTGN|OVID (Ovid Therapeutics) - Accounting Value of a Share|Net Assets per Single Share Acumen Pharmaceuticals, Inc. ABOS|Share Book Value CRVO|Alterity Therapeutics - Net Assets per Single Share|Net Asset Value per Share CLNN (clene.com)|Net Assets per Single Share PepGen|Accounting Value of a Share Jupiter Neurosciences, Inc. JUNS|Relmada Therapeutics, Inc. - Book Value per Share|Annovis Bio Inc (ANVS) - Book Value per Share|GRCE - Accounting Value per Share|Firefly Neuro (AIFF) - Book Price of a Share|KLTO: Book Value per Share|Net Assets per Share NRSN|Reviva Pharmaceuticals Holdings, Inc. - Net Assets per Single Share|Net Asset Value per Share MTVA (metaviatx.com)|NRXS - Net Assets per Single Share|Helius Medical Technologies, Inc. - Equity per Share|PASG (Passage Bio Corp) - Net Assets per Single Share|NEUP: Net Asset Value per Share|NERV (Minerva Neurosciences, Inc.) - Net Assets per Single Share|Athira Pharma Inc (ATHA) - Accounting Value per Share|Book Value per Share ADXN (Addex Therapeutics, Ltd.)|Net Asset Value per Share ALZN|Cyclerion Therapeutics (CYCN) - Net Assets per Single Share|Accounting Value of a Share PTIX (protagenic.com)|KTTA - Net Assets per Single Share|Equity per Share Cortigent Inc CRGT|ATXI (Avenue Therapeutics, Inc) - Book Value per Share|BrainStorm Cell Therapeutics Inc. (BCLI) - Net Asset Value per Share|CARA: Accounting Value per Share|CHRO (chromocell.com) - Book Value per Share|ELYM - Net Assets per Single Share|Accounting Value of a Share ITCI|Longboard Pharma - Net Assets per Single Share|Net Asset Value per Share MRNS (Marinus Pharma)|NKGN: Net Assets per Single Share|neurobopharma.com - Net Asset Value per Share|SAGE: Net Assets per Single Share|SNPX - Accounting Value per Share|Book Value per Share TRVN|VIGL (Vigil Neuroscience, Inc.) - Net Asset Value per Share|WENA - Net Assets per Single Share|Accounting Value of a Share CERE